image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates. 

Y2 receptor

Family: Neuropeptide Y receptors

Contents:
Gene and Protein Information
Previous and Unofficial Names
Database Links
Agonists
Antagonists
Transduction Mechanisms
Tissue Distribution
Expression Datasets
Functional Assays
Physiological Functions
Physiological Consequences of Altering Gene Expression
Phenotypes, Alleles and Disease Models
Biologically Significant Variants
General Comments
References
Gene and Protein Information
class A G protein-coupled receptor
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 7 381 4q31 NPY2R neuropeptide Y receptor Y2 3,21-22,45-46
Mouse 7 385 3 E3 Npy2r neuropeptide Y receptor Y2 35,39
Rat 7 381 2q31 Npy2r neuropeptide Y receptor Y2 24
Previous and Unofficial Names
neuropeptide Y receptor Y2
neuropeptide Y receptor Y2-like
neuropeptide Y receptor type 2
neuropeptide Y-Y2 receptor
neuropeptide Y/peptide YY-Y2 receptor
NPY-Y2 receptor
Database Links
ChEMBL Target
DrugBank Target
Ensembl
Entrez Gene
GeneCards
GenitoUrinary Development Molecular Anatomy Project
HomoloGene
Human Protein Reference Database
InterPro
KEGG Gene
OMIM
PharmGKB Gene
PhosphoSitePlus
Protein Ontology (PRO)
RefSeq Nucleotide
RefSeq Protein
TreeFam
UniGene Hs.
UniProt
Wikipedia
Search for 3D structures on the PDB
Search by keyword: Neuropeptide Y receptors Y2 receptor
Natural/Endogenous Ligand(s)
neuropeptide Y {Sp: Human, Mouse, Rat}
neuropeptide Y-(3-36) {Sp: Human, Mouse, Rat}
pancreatic polypeptide {Sp: Mouse} , pancreatic polypeptide {Sp: Rat} , pancreatic polypeptide {Sp: Human}
peptide YY {Sp: Human} , peptide YY {Sp: Mouse, Rat, Pig}
Rank order of potency (Human)
Agonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
[125I]PYY Hs Full agonist 9.6 pKd 46
[125I]NPY Hs Full agonist 9.2 pKd 46
peptide YY {Sp: Mouse, Rat, Pig} Rn Full agonist 10.0 pKi 24
PYY-(3-36) (pig) Rn Full agonist 9.9 pKi 24
peptide YY {Sp: Human} Hs Full agonist 9.5 – 9.8 pKi 21-22
peptide YY {Sp: Mouse, Rat, Pig} Hs Full agonist 9.5 pKi 22
PYY-(3-36) {Sp: Human} Hs Full agonist 9.2 – 9.7 pKi 21-22
neuropeptide Y {Sp: Human, Mouse, Rat} Rn Full agonist 9.4 pKi 24
neuropeptide Y {Sp: Human, Mouse, Rat} Hs Full agonist 9.3 – 9.5 pKi 21-22
NPY {Sp: Pig} Hs Full agonist 9.1 – 9.3 pKi 21-22
NPY-(3-36) (pig) Hs Full agonist 9.2 pKi 21
N-α-Ac-PYY-(25-36) (rat) Rn Full agonist 9.1 pKi 24
NPY-(3-36) (pig) Rn Full agonist 9.1 pKi 24
PYY-(13-36) (mouse, rat, pig) Hs Full agonist 8.8 – 9.4 pKi 21-22
NPY-(2-36) (pig) Hs Full agonist 8.6 – 9.3 pKi 21-22
NPY-(13-36) (human) Rn Full agonist 8.9 pKi 24
N-α-Ac-PYY-(22-36) (rat) Rn Full agonist 8.8 pKi 24
NPY-(2-36) Hs Full agonist 8.8 pKi 22
NPY-(13-36) (pig) Hs Full agonist 8.6 – 8.7 pKi 21-22
C2-NPY (pig) Hs Full agonist 8.5 pKi 22
NPY-(20-36) (pig) Hs Full agonist 8.5 pKi 22
NPY-(16-36) (pig) Hs Full agonist 8.2 pKi 22
NPY-(22-36) (pig) Hs Full agonist 7.4 pKi 22
[D-Trp32]NPY Rn Full agonist 7.3 pKi 24
[D-Trp32]NPY Hs Full agonist 6.8 pKi 21
NPY-(26-36) (pig) Hs Full agonist 6.5 pKi 22
[Pro34]PYY (human) Hs Full agonist 6.3 pKi 21
[Leu31,Pro34]NPY Hs Full agonist 6.2 pKi 22
[Leu31,Pro34]PYY (human) Hs Full agonist 6.2 pKi 21
[Leu31,Pro34]NPY (pig) Hs Full agonist 6.1 pKi 21
[Ala31,Aib32]NPY (pig) Hs Full agonist 6.1 pIC50 10
View species-specific agonist tables
Antagonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
BIIE0246 Rn Antagonist 8.0 pKi 24
BIIE0246 Hs Antagonist 8.5 pIC50 15
JNJ-5207787 Hs Antagonist 6.9 – 7.1 pIC50 8
View species-specific antagonist tables

Explore drug-target interactions for this set of compounds using iPHACE

Primary Transduction Mechanisms
Transducer Effector/Response
Gi/Go family Adenylate cyclase inhibition
Calcium channel
References:  37,50
Secondary Transduction Mechanisms
Transducer Effector/Response
Gq/G11 family Phospholipase C stimulation
References:  37
Tissue Distribution
Heart.
Species:  Human
Technique:  Immunohistochemistry.
References:  28
CNS: cortex, hippocampus, amygdala, choroid plexus, geniculate, hypothalamus, cerebellum.
Species:  Human
Technique:  in situ hybridisation.
References:  9
Ileum and colon.
Species:  Human
Technique:  RT-PCR.
References:  17
CNS: olfactory bulb, cortical areas, septum, basal forebrain, nucleus accumbens, amygdala, hippocampus, hypothalamus, substantia nigra compacta, locus coeruleus, solitary tract nucleus.
Species:  Mouse
Technique:  Immunohistochemistry.
References:  52
CNS: hypothalamus (preoptic nuclei, arcuate, dorsomedial, and perifornical nuclei, A13 dopaminergic neurons).
Species:  Mouse
Technique:  Immunohistochemistry.
References:  18
Brain: hippocampus, hypothalamus, amygdala, specific nuclei of the brainstem.
Species:  Rat
Technique:  in situ hybridisation.
References:  41
CNS: cortex, hippocampus, amygdala, thalamus, hypothalamus, mesencephalon, pons.
Species:  Rat
Technique:  in situ hybridisation.
References:  26
Large and small intestine (epithelial and nonepithelial tissue).
Species:  Rat
Technique:  RT-PCR.
References:  23
Aorta, pulmonary artery.
Species:  Rat
Technique:  RT-PCR.
References:  5
Expression Datasets

Click here to show/hide data

Log average relative transcript abundance in mouse tissues measured by qPCR from Regard, J.B., Sato, I.T., and Coughlin, S.R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell, 135(3): 561-71. [PMID:18984166] [Raw data: website]

There should be a chart of expression data here, you may need to enable JavaScript!
Functional Assays
Measurement of Ca2+ levels in human neuroblastoma CHP-234 cells endogenously expressing the Y2 receptor.
Species:  Human
Tissue:  CHP-234 cells.
Response measured:  Stimulation of Ca2+ accumulation.
References:  36
Measurement of cAMP levels in human neuroblastoma SMS-KAN cells endogenously expressing the Y2 receptor.
Species:  Human
Tissue:  SMS-KAN cells.
Response measured:  Inhibition of forskolin-stimulated cAMP accumulation.
References:  50
Measurement of Ca2+ levels in human neuroblastoma SMS-KAN cells endogenously expressing the Y2 receptor.
Species:  Human
Tissue:  SMS-KAN cells.
Response measured:  Stimulation of Ca2+ release from intracellular stores and K+-induced Ca2+ influx.
References:  50
Physiological Functions
Inhibition of food intake.
Species:  Rat
Tissue:  In vivo.
References:  7,49
Inhibition of food intake.
Species:  Human
Tissue:  In vivo.
References:  6-7
Modulation of duodenal motility.
Species:  Rat
Tissue:  In vivo.
References:  19
Stimulation of non-rapid eye movement sleep.
Species:  Rat
Tissue:  In vivo (eye).
References:  1
Angiogenesis.
Species:  Rat
Tissue:  In vivo.
References:  57
Modulation of anxiety-related behaviour.
Species:  Mouse
Tissue:  In vivo.
References:  38
Modulation of anxiety-related behaviour.
Species:  Rat
Tissue:  In vivo.
References:  30,48
Stimulation of ethanol consumption.
Species:  Rat
Tissue:  In vivo.
References:  54
Contraction.
Species:  Rat
Tissue:  Colon.
References:  20,42
Inhibition of electrogenic ion transport.
Species:  Human
Tissue:  Isolated descending colon.
References:  13
Inhibition of electrogenic ion transport.
Species:  Mouse
Tissue:  Colonic mucosal preparaions.
References:  14
Presynaptic inhibition.
Species:  Rat
Tissue:  Hippocampal slices.
References:  12
Physiological Consequences of Altering Gene Expression
Y2 receptor knockout mice exhibit potentiation of pentobarbital-induced sedation.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  40
Y2 receptor knockout mice exhibit alterations in bone homeostasis.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  2,4
Hypothalamus-specific Y2 receptor knockout mice exhibit a decrease in body weight, increase in food intake and an increase in plasma concentrations of pancreatic polypeptide and corticosterone.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  47
Y2 receptor knockout mice do not exhibit inhibition of food intake, as seen in wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  6-7
Y2 receptor knockout mice do not exhibit agonist-induced angiogenesis, as seen in wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  16,32-33
Y2 receptor knockout mice exhibit delayed wound healing.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  16
Y2 receptor knockout mice exhibit reduced levels of anxiety-related behaviour compared to wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  11,25,43,55
Y2 receptor knockout mice exhibit impaired learning and memory.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  44
Y2 receptor knockout mice exhibit a decrease in ethanol consumption and an increase in water consumption.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  53
Y2 receptor knockout mice do not exhibit resetting of the circadian clock, as seen in wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  51
Y2 receptor knockout mice exhibit an increase in water consumption during the dark phase.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  56
Y2 receptor knockout mice do not exhibit the antagonist-induced increase in mucosal ion transport as seen in wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  27
Phenotypes, Alleles and Disease Models Mouse data from MGI

Click here to show/hide data

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0005452 abnormal adipose tissue amount PMID: 12453895 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0002896 abnormal bone mineralization PMID: 11927618 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0002896 abnormal bone mineralization PMID: 12861009 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0008271 abnormal bone ossification PMID: 11927618 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0003795 abnormal bone structure PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0000130 abnormal cancellous bone morphology PMID: 11927618 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0000130 abnormal cancellous bone morphology PMID: 11927618 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0000130 abnormal cancellous bone morphology PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0000130 abnormal cancellous bone morphology PMID: 12861009 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0000188 abnormal circulating glucose level PMID: 12453895 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0005418 abnormal circulating hormone level PMID: 12072562 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0001560 abnormal circulating insulin level PMID: 12453895 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001560 abnormal circulating insulin level PMID: 12072562 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0008459 abnormal circulating pancreatic peptide level PMID: 12072562 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0008459 abnormal circulating pancreatic peptide level PMID: 12072562 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0008459 abnormal circulating pancreatic peptide level PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0008459 abnormal circulating pancreatic peptide level PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001422 abnormal drinking behavior PMID: 16364461 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0005449 abnormal food intake PMID: 10502824 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0005449 abnormal food intake PMID: 12072562 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ
MGI:108418  MP:0005449 abnormal food intake PMID: 16950139 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0003953 abnormal hormone level PMID: 17272395 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:105374  MGI:108418  MP:0003953 abnormal hormone level PMID: 17272395 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0000477 abnormal intestine morphology PMID: 12453895 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0002801 abnormal long term object recognition memory PMID: 14997009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0006092 abnormal olfactory neuron morphology PMID: 18305161 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0005006 abnormal osteoblast physiology PMID: 12861009 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0000057 abnormal osteogenesis PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0004275 abnormal postnatal subventricular zone morphology PMID: 18305161 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0004279 abnormal rostral migratory stream morphology PMID: 18305161 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv
MGI:108418  MP:0001501 abnormal sleep pattern PMID: 11579129 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001463 abnormal spatial learning PMID: 14997009 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/cJ
MGI:108418  MP:0002570 alcohol aversion PMID: 15203244 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv
MGI:108418  MP:0002862 altered righting response PMID: 11579129 
Npy1rtm1Pern|Npy2rtm1Pern Npy1rtm1Pern/Npy1rtm1Pern,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv
MGI:104963  MGI:108418  MP:0002862 altered righting response PMID: 11579129 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001364 decreased anxiety-related response PMID: 12742262 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001262 decreased body weight PMID: 12072562 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001262 decreased body weight PMID: 12072562 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0001262 decreased body weight PMID: 12126735 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0001262 decreased body weight PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0001262 decreased body weight PMID: 12861009 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0001780 decreased brown adipose tissue amount PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0002665 decreased circulating corticosterone level PMID: 12453895 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0002665 decreased circulating corticosterone level PMID: 12453895 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0002702 decreased circulating free fatty acid level PMID: 12126735 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0005560 decreased circulating glucose level PMID: 12126735 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0002727 decreased circulating insulin level PMID: 12072562 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0002727 decreased circulating insulin level PMID: 12861009 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0000183 decreased circulating LDL cholesterol level PMID: 12126735 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0005668 decreased circulating leptin level PMID: 12861009 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0002780 decreased circulating testosterone level PMID: 12453895 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0000135 decreased cortical bone thickness PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0003910 decreased eating behavior PMID: 12072562 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0003910 decreased eating behavior PMID: 12861009 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0004890 decreased energy expenditure PMID: 10502824 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0009289 decreased epididymal fat pad weight PMID: 12453895 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0003961 decreased lean body mass PMID: 12453895 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0009299 decreased mesenteric fat pad weight PMID: 12453895 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0004981 decreased neuronal precursor cell number PMID: 18305161 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0004985 decreased osteoclast cell number PMID: 11927618 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0004985 decreased osteoclast cell number PMID: 12861009 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0004852 decreased testis weight PMID: 12453895 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001783 decreased white adipose tissue amount PMID: 12072562 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0001783 decreased white adipose tissue amount PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0001783 decreased white adipose tissue amount PMID: 12861009 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0001926 female infertility PMID: 12000791 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0001402 hypoactivity PMID: 10502824 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0001260 increased body weight PMID: 10502824 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0001260 increased body weight PMID: 12453895 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0009347 increased cancellous bone thickness PMID: 11927618 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0009347 increased cancellous bone thickness PMID: 11927618 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0009347 increased cancellous bone thickness PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:108418  MP:0009347 increased cancellous bone thickness PMID: 12861009 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0005178 increased circulating cholesterol level PMID: 12453895 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0005178 increased circulating cholesterol level PMID: 12126735 
Npy2rtm1Hhz Npy2rtm1Hhz/Npy2rtm1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0001745 increased circulating corticosterone level PMID: 11927618  12072562 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0001556 increased circulating HDL cholesterol level PMID: 12126735 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0004702 increased circulating insulin-like growth factor I level PMID: 17272395 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:105374  MGI:108418  MP:0004702 increased circulating insulin-like growth factor I level PMID: 17272395 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0001552 increased circulating triglyceride level PMID: 12453895 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0003911 increased drinking behavior PMID: 16364461 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/cJ
MGI:108418  MP:0003911 increased drinking behavior PMID: 15203244 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * BALB/cJ * C57BL/6
MGI:105374  MGI:108418  MP:0003909 increased eating behavior PMID: 12861009 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0005137 increased growth hormone level PMID: 17272395 
Npy2rtm1.1Hhz|Ppyr1tm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz,Ppyr1tm1.1Hhz/Ppyr1tm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:105374  MGI:108418  MP:0005137 increased growth hormone level PMID: 17272395 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0002626 increased heart rate PMID: 10502824 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0003917 increased kidney weight PMID: 12453895 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0002981 increased liver weight PMID: 12453895 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0009108 increased pancreas weight PMID: 12453895 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0009766 increased sensitivity to xenobiotic induced morbidity/mortality PMID: 16650144 
Npy2rtm1.1Hhz Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:108418  MP:0002906 increased susceptibility to pharmacologically induced seizures PMID: 16650144 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0008908 increased total fat pad weight PMID: 10502824 
Lepob|Npy2rtm1Pern Lepob/Lepob,Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c * STOCK Mlph a Tgfa Cdh23 Ednrb
MGI:104663  MGI:108418  MP:0005317 increased triglyceride level PMID: 12126735 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0001925 male infertility PMID: 12000791  12453895 
Npy2rtm1Pern Npy2rtm1Pern/Npy2rtm1Pern
involves: 129/Sv * BALB/c
MGI:108418  MP:0001433 polyphagia PMID: 10502824 
Lepob|Npy2rtm1.1Hhz Lepob/Lepob,Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
involves: 129X1/SvJ * C57BL/6
MGI:104663  MGI:108418  MP:0001433 polyphagia PMID: 12453895 
Biologically Significant Variants
A Thr585 -> Cys polymorphism has been linked to obesity in Swedish Caucasian men.
Type:  Single nucleotide polymorphism.
Species:  Human
References:  31
General Comments
For a review on NPY receptor knockout mice see [34].
For a review on the functions of the Y2 receptor see [29].

REFERENCES

To cite this database page, please use the following:

Annette Beck-Sickinger, William F. Colmers, Helen M. Cox, Henri N. Doods, Herbert Herzog, Dan Larhammar, Martin C. Michel, Remi Quirion, Thue Schwartz, Thomas Westfall.
Neuropeptide Y receptors: Y2 receptor. Last modified on 15/02/2013. Accessed on 26/05/2013. IUPHAR database (IUPHAR-DB), http://iuphar-db.org/DATABASE/ObjectDisplayForward?objectId=306.


Contact us | Print | Back to top | Help